ABVC BioPharma, Inc. (ABVC) Operating income 2017–2025
ABVC BioPharma, Inc. (ABVC) annual operating income history from SEC filings — each fiscal year as reported.
-$7.2MFY2025 · since FY2017: -$4.1M → -$7.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.2M | -52.0% |
| FY2024 | -$4.7M | +30.5% |
| FY2023 | -$6.8M | +55.2% |
| FY2022 | -$15.1M | -29.1% |
| FY2021 | -$11.7M | -37.6% |
| FY2020 | -$8.5M | -145.9% |
| FY2019 | -$3.5M | -24.2% |
| FY2018 | -$2.8M | +32.7% |
| FY2017 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABVC financial trends
ABVC RevenueABVC Net incomeABVC Net marginABVC Gross profitABVC Gross marginABVC Operating marginABVC Operating cash flowABVC Free cash flowABVC Capital expendituresABVC Return on equityABVC Stock buybacksABVC Dividends paidABVC Total assetsABVC Total liabilitiesABVC Shareholders’ equityABVC overview →